These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8346797)

  • 1. Reversal of atracurium after low dose tubocurarine.
    Nott MR; Tanner V
    Anaesthesia; 1993 Jul; 48(7):644. PubMed ID: 8346797
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular changes at antagonism of atracurium. Effects of different doses of premixed neostigmine and glycopyrronium in a ratio of 5:1.
    Suresh D; Carter JA; Whitehead JP; Goldhill DR; Flynn PJ
    Anaesthesia; 1991 Oct; 46(10):877-80. PubMed ID: 1952007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of non-depolarising neuromuscular block in children: a comparison of atropine and glycopyrrolate in a mixture with neostigmine.
    Black GW; Mirakhur RK; Keilty SR; Love SH
    Anaesthesia; 1980 Sep; 35(9):913-6. PubMed ID: 7446931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of neuromuscular blockade with a mixture of neostigmine and glycopyrrolate.
    Klingenmaier CH; Bullard R; Thompson D; Watson R
    Anesth Analg; 1972; 51(3):468-72. PubMed ID: 5064029
    [No Abstract]   [Full Text] [Related]  

  • 5. Atracurium after an anticholinesterase. Does prior reversal with edrophonium or neostigmine influence the response to atracurium?
    Shorten GD; Ali HA
    Anaesthesia; 1993 Jun; 48(6):524-6. PubMed ID: 8322995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of neuromuscular blockade.
    Millar SW; Lamb CJ; Liban JB
    Br J Anaesth; 1985 Oct; 57(10):1043-4. PubMed ID: 4041317
    [No Abstract]   [Full Text] [Related]  

  • 7. Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia.
    Ording H; Nielsen VG
    Br J Anaesth; 1986 Sep; 58(9):1001-4. PubMed ID: 3092848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible curarization.
    Baraka A
    Anaesth Intensive Care; 1977 Aug; 5(3):244-6. PubMed ID: 332002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of atracurium neuromuscular block with neostigmine in the dog.
    Jones RS
    Res Vet Sci; 1990 Jan; 48(1):96-8. PubMed ID: 2300723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of intense neuromuscular blockade following infusion of atracurium.
    Engbaek J; Ostergaard D; Skovgaard LT; Viby-Mogensen J
    Anesthesiology; 1990 May; 72(5):803-6. PubMed ID: 2160206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
    Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function.
    Hunter JM; Jones RS; Utting JE
    Br J Anaesth; 1984 Sep; 56(9):941-51. PubMed ID: 6147153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
    Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
    Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming reversal of profound atracurium blockade by edrophonium and neostigmine.
    Liu CH; Lin IS; Liu CG; Peng TH; Yeh YJ; Chuu LJ; Lin SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 May; 11(5):257-64. PubMed ID: 7602663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of blockade produced by atracurium or vecuronium with low doses of neostigmine.
    Jones JE; Parker CJ; Hunter JM
    Br J Anaesth; 1988 Nov; 61(5):560-4. PubMed ID: 2905146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neostigmine in the antagonism of the action of atracurium.
    Fox MA; Keens SJ; Utting JE
    Br J Anaesth; 1987 Apr; 59(4):468-72. PubMed ID: 3566998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.